Study design: Fifty-one consecutive patients (66±10 years, 49 male) who underwent catheter ablation for symptomatic VPCs were included into the study. Twenty-seven patients were aged >65 years and 24 patients ≤65 years. Frequency of VPCs per total heart beats by 24-hour Holter monitoring, LV ejection fraction (LVEF) and end-systolic diameters (LVEDD) were evaluated before and 6±3 months after ablation.
I
ncreased burden of ventricular premature complexes (VPCs) have been identified as a possible cause of left ventricular (LV) systolic dysfunction. [1] Prior studies have shown that marked decreases in VPC burden result in improvement in LV systolic function and in a decrease in symptoms in a certain subset of patients. [2, 3] In the last decade, catheter-based ablation therapy has become a safe and effective treatment option for patients with symptomatic VPCs. [3] With improved safety, the therapy has the potential to be a first-line therapy for older populations since antiarrhythmic therapy is often complicated by serious adverse effects of these drugs in this age group. [4] However, arrhythmia mechanisms, medical comorbidities, and safety of the ablation therapy may vary in the elderly population.
The purpose of this study was to assess and compare the short-term outcome of catheter ablation of frequent VPCs in younger and older patients.
PATIENTS AND METHODS

Patient characteristics
We enrolled 69 consecutive patients who underwent catheter ablation for the treatment of symptomatic frequent VPCs between March 2008 and April 2012. We excluded patients with atrial fibrillation/flutter (n=6), those with permanent pacemaker therapy (n=4) and patients with inadequate echocardiographic images (n=8). The final study cohort included 51 patients. This study was approved by the Institutional Research Board of our center.
Holter recordings
The VPC burden was calculated as the number of VPCs divided by the number of all QRS complexes during 24 hours x 100 and was measured using a 24-hour Holter monitor before and after the ablation. A decrease of >80% in the VPC burden was defined as a successful outcome. All class I and class III antiarrhythmic drugs were withheld >5 half-lives before the procedure.
Transthoracic echocardiography
All patients underwent transthoracic echocardiography (TTE) before and 6±3 months after ablation. Echocardiography was performed using standard views and harmonic imaging (Sequoia, Siemens, Mountain View, CA, USA). Left atrium (LA) maximum anteroposterior diameter was measured in the parasternal long-axis views. The LV end-diastolic and end-systolic volumes, LV stroke volume index, and LV ejection fraction (EF; calculated by Simpson's method) were measured in the apical fourchamber view. LA volumes were calculated by twodimensional echocardiography by the biplane arealength method. Maximal LA volume (LAVmax) was obtained just before mitral valve opening. Minimal LA volume (LAVmin) was determined at the time of mitral valve closure. LA areas (A1, A2) and superoinferior longitudinal diameters were measured from apical four-and two-chamber views. LAVs were calculated by the following formula: LAV = 0.85 x A1 x A2/L, where L is the shorter supero-inferior diameter measured from the midline of the mitral annulus to the opposite wall of the LA. [5] LAV index (LAVI) was calculated by dividing maximal LA volume by the body surface area (LAVmax/BSA).
Mapping and ablation procedure
The sites of VPCs were mapped based on the morphology of the VPCs as described previously. [6] Right or left ventricles and/or outflow tracts were reconstructed using Soundstar 3D Catheter, which integrates real-time intracardiac echocardiography (ICE) imaging ( All patients in this study had acute procedural success, defined as absence of spontaneous or inducible VPCs with isoproterenol infusion. Patients were reassessed for 30 minutes following the successful ablation to confirm no recurrence of VPCs.
Statistical analysis
Statistical analysis was performed using STATA11 (Stata-Corp, College Station, TX, USA). Categorical variables are presented as number or percentages, whereas continuous variables are presented as mean ± standard deviation. Pearson chi-square or Fisher's exact tests were used to assess the statistical significance of categorical data. Student's t test was used to test the statistical significance of continuous variables. A comparison of the LAV and echocardiographic vari- follow-up. Pericardial tamponade requiring percutaneous drainage occurred in one patient (in the younger group).
The mean heart rate remained unchanged after the procedure in both groups (67.5±9.4 bpm vs. 70.1±9.3 bpm; p=0.62 for >65 years group and 69.2±9.9 bpm vs. 74.1±9.3 bpm; p=0.37 for ≤65 years group). Mean LVEF showed a significant increase in both groups (Fig. 2) . The improvement in LVEF was accompanied by a significant decrease in both LVEDD and left atrial diameter ( Table 2 ).
The mean VPC burden had decreased from 31±15.3% to 9.1±10.3% (p<0.001) in patients >65 ables prior to and after VPC ablation was performed using paired Student's t test. Differences were considered significant at a p value of <0.05.
RESULTS
The study population reported here included 51 patients (49 male, mean age: 66±10 years). Twentyseven (26 male, 73±6 years) patients were included in the older group (>65 years), whereas 24 patients (23 male, 57±7 years) were categorized into the younger group (≤65 years). Table 1 summarizes the baseline characteristics of the two groups. Patients aged >65 years had a higher prevalence of hypertension (p=0.019). There was no difference between the two groups based on prevalence of coronary artery disease, cardiomyopathy and diabetes (p=1.0, p=0.49 and p=0.84, respectively).
The VPC morphology, VPC axis, VPC origin site, and VPC QRS width were comparable between the two groups ( Table 1 ). The pre-ablation 24-hour VPC burden (calculated by dividing the number of VPCs by the total number of beats) and VPC number were significantly higher in patients aged >65 years (p=0.04 and p=0.026, respectively; Fig. 1 ).
Clinical outcomes and LV systolic function after VPC ablation
Twenty-two patients (81.5%) aged >65 years and 21 patients (87.5%) ≤65 years had successful ablation, defined as >80% reduction in VPC burden at followup. One patient in the younger group died during the years and from 21.9±12.6 to 3.8±7.1 (p<0.001) in patients ≤65 years in 3-8 months after catheter ablation (Fig. 3) .
Analysis of LAV demonstrated a significant decrease in LAVmax in patients aged >65 years (p=0.002) and ≤65 years (p=0.01) after VPC ablation (Fig. 4a) . At baseline, mean LAVI was severely increased in the study population: 49.7±14.7 ml/m 2 for the older group and 43.3±12.6 ml/m 2 for the younger group (normal LAVmax/BSA: <29 ml/m 2 ). After the procedure, LAVI decreased significantly in both groups but remained abnormal (Fig. 4b) .
DISCUSSION
This study revealed that catheter-based treatment of VPCs reduces VPC burden, improves LV systolic function, and decreases LAV in patients both >65 years and ≤65 years of age, and there is no incremental risk associated with older patients.
The occurrence of VPCs is more common in patients with structural heart disease. Male gender, faster sinus rate, electrolyte abnormalities, hypertension, and increased age are other risk factors for frequent VPCs. [7, 8] Simpson et al. reported that the prevalence of VPCs shows a 34% increase for each five-year increment in age. [7] The age-related increase in the prevalence of VPCs was demonstrated in both normal individuals and those with underlying heart disease. [8] In accordance with the above-mentioned studies, the frequency of VPCs in the present study was found to be higher in the older group than in patients ≤65 years. In addition, the ARIC study demonstrated that patients with hypertension have more frequent VPCs than the non-hypertensive group. [7] In our study, the prevalence of hypertension was significantly higher in patients >65 years than in the younger group, which might be another reason for the higher VPC burden in the older group. Although the exact mechanisms of frequent VPC in the presence of increased age and hypertension is still not clear, we speculate that since both conditions are related to an increased fibrotic process in the myocardial tissue, the conduction delay in fibrotic areas serves as a substrate for reentry and triggered activity that results in frequent VPCs. We also found that catheter ablation resulted in a significant decrease in VPC burden in both the older and younger patients. A study done by Baman et al. [9] reported that VPC burden was reduced by ≥80% by catheter ablation in 84% of the patients. The success rate in our study was 81.5% in patients aged >65 years and 87.5% in those ≤65 years, showing comparable results between the two groups.
Catheter-based ablation is an effective treatment for patients with frequent and symptomatic VPCs. [10] In addition to improving symptoms, reduction in VPC burden may play a role in improvement in LV systolic functions after the procedure. Catheter ablation of VPCs is thought to improve LVEF through several mechanisms, including better rate control, restoration of atrioventricular transport function and regaining of ventricular synchrony. [11] Previous studies report the average increase in LVEF following successful catheter ablation of VPCs as ranging between 4% and 24%. [11, 12] Bogun et al. [11] evaluated the efficacy of VPC ablation in patients with VPC-induced cardiomyopathy and reported that LVEF increased from 34% to 59% within six months following ablation. A recent study by Lü et al. [12] on the efficacy of catheter ablation in 24 patients with asymptomatic frequent VPCs reported an average 11% increase in LVEF at the eighthmonth follow-up after ablation. In the present study, catheter ablation of VPCs also resulted in a significant increase in LVEF, supporting these prior reports. However, to our best knowledge, this is the first study comparing the efficacy of VPC ablation in both the older and younger groups. Our results indicate that the ablation-based therapy in older patients is as effective as in younger patients, and the improvement in LVEF seems to be similar between the two groups.
Another finding in this study was that catheter ablation of VPCs resulted in a significant decrease in LAV. In accordance with our study, Kim et al. also reported improvement in LAVI approximately one year after VPC ablation. The main improvement in their study was observed among patients with VPC from right ventricle outflow track (RVOT)-origin, and LAVI nearly reached normal value after ablation. [13] However, mean LAV in our study was still higher at the follow-up. A possible explanation is that short-term echocardiographic assessment is inadequate for reversal of structural remodeling in the LA after ablation, and we speculate that the results after one year would show lower LAVs. Most of the studies evaluating reversal of atrial remodeling were done using drugs [14] or catheter-based treatment of atrial fibrillation [15] and had a follow-up of over one year. On the other hand, left atrial remodeling is reversible, particularly in the earlier stages of LA structural disturbances. [16] Since the baseline LAVI value in our study population was higher than that reported by Kim et al.'s group, it is reasonable to think that we had more patients with advanced stage of LA structural dysfunction who had ir-reversible LA remodeling and thus demonstrated less improvement after ablation.
Limitations
The primary limitation of our study was the relatively short follow-up period post-ablation to ascertain the long-term effects. Assessing ventricular function postablation after one year or more of follow-up may show more robust changes than seen in our study. Second, the assessment of pre-ablation and post-ablation VPC burden was done by a single 24-hour Holter monitor. Since frequency of VPCs is variable, a single monitor may not accurately represent the real burden of VPCs. However, several previous studies have used the same method to assess VPC burden. [3, 6] Third, we used TTE for the assessment of LV function. Although invasive measurements are the gold standard for assessment of diastolic function, the accuracy of echocardiography has been validated in several prior studies. [17, 18] Fourth, patients in this study were predominantly males of relatively older ages. The outcomes in females and young subjects may vary. Finally, the sample size in the present study was relatively small. Larger studies are needed in order to make more substantive conclusions regarding the improvement in diastolic parameters following VPC ablation.
In conclusion, catheter ablation reduced VPC burden, improved LV systolic function and decreased LAV in patients with frequent VPCs. The improvement occurs in both younger and older patients, and there is no incremental risk associated with older patients.
